drugset / Trial / NCT00469456

Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease

NCT00469456

Phase 4 Completed 265 enrolled Forest Laboratories
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to evaluate the effect of memantine versus placebo on functional communication in patients with Alzheimer's Disease

Timeline

Start
2007-04
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Memantine Unknown 10 mg Oral

Indications